Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Literature DB >> 22324021

A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Robert W Shafer¹, Kathryn Dupnik, Mark A Winters, Susan H Eshleman.

Abstract

Entities: Species

Year: 2001 PMID： 22324021 PMCID： PMC3274565

Source DB: PubMed Journal: HIV Seq Compend ISSN： 2151-7983

× No keyword cloud information.

263 in total

1. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries.

Authors: R W Shafer; D R Jung; B J Betts
Journal: Nat Med Date: 2000-11 Impact factor: 53.440

2. Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response.

Authors: N S Shulman; A R Zolopa; D J Passaro; U Murlidharan; D M Israelski; C L Brosgart; M D Miller; S Van Doren; R W Shafer; D A Katzenstein
Journal: J Acquir Immune Defic Syndr Date: 2000-03-01 Impact factor: 3.731

Review 3. Sequence variability in human immunodeficiency viruses: pattern and process in viral evolution.

Authors: A J Brown
Journal: AIDS Date: 1991 Impact factor: 4.177

4. Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing.

Authors: B A Larder; A Kohli; P Kellam; S D Kemp; M Kronick; R D Henfrey
Journal: Nature Date: 1993-10-14 Impact factor: 49.962

5. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.

Authors: N Yahi; J Fantini; C Tourres; N Tivoli; N Koch; C Tamalet
Journal: J Infect Dis Date: 2001-03-27 Impact factor: 5.226

6. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms.

Authors: M Vahey; M E Nau; S Barrick; J D Cooley; R Sawyer; A A Sleeker; P Vickerman; S Bloor; B Larder; N L Michael; S A Wegner
Journal: J Clin Microbiol Date: 1999-08 Impact factor: 5.948

7. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors: A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal: Proc Natl Acad Sci U S A Date: 1993-07-01 Impact factor: 11.205

8. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.

Authors: Z Gu; Q Gao; H Fang; H Salomon; M A Parniak; E Goldberg; J Cameron; M A Wainberg
Journal: Antimicrob Agents Chemother Date: 1994-02 Impact factor: 5.191

9. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

Authors: T Shirasaka; M F Kavlick; T Ueno; W Y Gao; E Kojima; M L Alcaide; S Chokekijchai; B M Roy; E Arnold; R Yarchoan
Journal: Proc Natl Acad Sci U S A Date: 1995-03-14 Impact factor: 11.205

10. Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.

Authors: S F Lacey; B A Larder
Journal: Antimicrob Agents Chemother Date: 1994-06 Impact factor: 5.191

14 in total

1. Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples.

Authors: Sarah Palmer; Dominique Vuitton; Matthew J Gonzales; Agnés Bassignot; Robert W Shafer
Journal: J Acquir Immune Defic Syndr Date: 2002-11-01 Impact factor: 3.731

2. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.

Authors: Rami Kantor; Lynn S Zijenah; Robert W Shafer; Solomon Mutetwa; Elizabeth Johnston; Robert Lloyd; Andrea von Lieven; Dennis Israelski; David A Katzenstein
Journal: AIDS Res Hum Retroviruses Date: 2002-12-10 Impact factor: 2.205

3. HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.

Authors: Luke C Swenson; Jeong Eun Min; Conan K Woods; Eric Cai; Jonathan Z Li; Julio S G Montaner; P Richard Harrigan; Alejandro Gonzalez-Serna
Journal: AIDS Date: 2014-05-15 Impact factor: 4.177

Review 4. HIV-1 antiretroviral drug therapy.

Authors: Eric J Arts; Daria J Hazuda
Journal: Cold Spring Harb Perspect Med Date: 2012-04 Impact factor: 6.915

5. Laboratory Optimization Tweaks for Sanger Sequencing in a Resource-Limited Setting.

Authors: Chika K Onwuamah; Azuka P Okwuraiwe; Rahaman A Ahmed; Judith O Sokei; Jamda Ponmak; Leona C Okoli; Brian A Kagurusi; Joseph Anejo-Okopi
Journal: J Biomol Tech Date: 2020-12

6. Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait.

Authors: Wassim Chehadeh; Osama Albaksami; Sonia Elezebeth John; Widad Al-Nakib
Journal: Med Princ Pract Date: 2018-03-05 Impact factor: 1.927

Review 7. Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.

Authors: Ashley N Matthew; Florian Leidner; Gordon J Lockbaum; Mina Henes; Jacqueto Zephyr; Shurong Hou; Desaboini Nageswara Rao; Jennifer Timm; Linah N Rusere; Debra A Ragland; Janet L Paulsen; Kristina Prachanronarong; Djade I Soumana; Ellen A Nalivaika; Nese Kurt Yilmaz; Akbar Ali; Celia A Schiffer
Journal: Chem Rev Date: 2021-01-07 Impact factor: 60.622